Nektar Therapeutics (NASDAQ:NKTR)

86.21
Delayed Data
As of Apr 20
 -3.94 / -4.37%
Today’s Change
17.33
Today|||52-Week Range
111.36
+44.36%
Year-to-Date

Today’s Trading

Previous close90.15
Today’s open89.82
Day’s range85.47 - 90.66
Volume3,089,896
Average volume (3 months)2,843,418
Market cap$17.4B
Data as of 4:00pm ET, 04/20/2018

Growth & Valuation

Earnings growth (last year)+43.64%
Earnings growth (this year)-132.26%
Earnings growth (next 5 years)-7.38%
Revenue growth (last year)+86.00%
P/E ratioNM
Price/Sales30.27
Price/Book196.78

Competitors

 Today’s
change
Today’s
% change
ONCESpark Therapeutics I...+0.23+0.28%
AVXSAveXis Inc-2.24-1.07%
XONIntrexon Corp-0.14-0.77%
BPMCBlueprint Medicines ...-1.29-1.55%
Data as of 4:01pm ET, 04/20/2018

Financials

Next reporting dateMay 9, 2018
EPS forecast (this quarter)-$0.36
Annual revenue (last year)$307.7M
Annual profit (last year)-$96.7M
Net profit margin-31.42%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Howard W. Robin
Chief Operating Officer &
Senior Vice President
John Nicholson
Corporate headquarters
San Francisco, California

Forecasts